Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
Thomas Powles(Queen Mary University of London), Kobe Yuen, Silke Gillessen(Institute of Oncology Research), Edward E. Kadel, Dana E. Rathkopf(Memorial Sloan Kettering Cancer Center), Nobuaki Matsubara(National Cancer Center Hospital East), Charles G. Drake(Columbia University Irving Medical Center), Karim Fizazi(Université Paris-Saclay), Josep M. Piulats(Institut d'Investigació Biomédica de Bellvitge), Piotr J. Wysocki(Jagiellonian University), Gary L. Buchschacher(Kaiser Permanente), B. Yа. Alekseev(Tomsk Cancer Research Institute), Begoña Mellado(Universitat de Barcelona), Bogusława Karaszewska, Jennifer Doss(Global Blood Therapeutics (United States)), Grozdana Rasuo(Roche (Switzerland)), Asim Datye(Roche (Switzerland)), Sanjeev Mariathasan, Patrick Williams, Christopher J. Sweeney(Dana-Farber Cancer Institute)
Cited by 240Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis